Literature DB >> 8106552

Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis.

P Chen1, K Gupta, A Wells.   

Abstract

The EGF receptor (EGFR) upon activation signals increased cell movement. However, the domains within the receptor, and the pathway which trigger movement are undefined. We expressed EGFR mutants at physiologic levels in receptor-devoid NR6 cells to investigate this biologic response. The receptors possessed kinase activity and underwent autophosphorylation as predicted by primary amino acid sequence. EGF-induced cell motility was assessed in vitro by excess migration into an acellular area and colony scatter in the presence of saturating concentrations of EGF. Wild-type (WT)-EGFR signaled increased motility. However, replacing the conserved lysine721 with methionine resulted in a kinase-inactive receptor which did not elicit movement. Removal of the entire terminus by truncation (c'973) also abrogated ligand-induced motility. Thus, we concentrated on the carboxy-terminal domains. EGF-induced movement was seen with a less-truncated mutant (c'1000) that contained a single autophosphorylated tyrosine (tyrosine992). Other mutants, c'991 and c'1000F992, in which this tyrosine was removed did not signal motility. Fusion mutants which presented other autophosphorylated tyrosine domains also exhibited EGF-induced movement. These findings suggested that the presence of both an autophosphorylated tyrosine signaling domain and the kinase activity are necessary for this biologic response. All kinase-positive mutants signaled cell proliferation but only those that contained autophosphorylatable tyrosines induced movement. The motility responses mediated by these EGFR were identical in the presence or absence of mitomycin-C, at a dose (0.5 micrograms/ml) which completely inhibited cell proliferation. On the other side, D-actinomycin (50 ng/ml) blocked EGF-induced motility but did not affect thymidine incorporation. Thus, EGF-induced mitogenesis and cell motility are mediated through different pathways.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8106552      PMCID: PMC2119923          DOI: 10.1083/jcb.124.4.547

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  53 in total

1.  In vitro model of angiogenesis using a human endothelium-derived permanent cell line: contributions of induced gene expression, G-proteins, and integrins.

Authors:  J Bauer; M Margolis; C Schreiner; C J Edgell; J Azizkhan; E Lazarowski; R L Juliano
Journal:  J Cell Physiol       Date:  1992-12       Impact factor: 6.384

Review 2.  Receptor tyrosine kinase substrates: src homology domains and signal transduction.

Authors:  G Carpenter
Journal:  FASEB J       Date:  1992-11       Impact factor: 5.191

3.  Identification of residues in GTPase-activating protein Src homology 2 domains that control binding to tyrosine phosphorylated growth factor receptors and p62.

Authors:  L E Marengere; T Pawson
Journal:  J Biol Chem       Date:  1992-11-15       Impact factor: 5.157

4.  The small GTP-binding protein rac regulates growth factor-induced membrane ruffling.

Authors:  A J Ridley; H F Paterson; C L Johnston; D Diekmann; A Hall
Journal:  Cell       Date:  1992-08-07       Impact factor: 41.582

Review 5.  Epidermal growth factor.

Authors:  G Carpenter; S Cohen
Journal:  Annu Rev Biochem       Date:  1979       Impact factor: 23.643

6.  Shaking 3T3 cells: further studies on diffusion boundary effects.

Authors:  M Stoker; D Piggott
Journal:  Cell       Date:  1974-11       Impact factor: 41.582

7.  Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus.

Authors:  R Mann; R C Mulligan; D Baltimore
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

8.  A limited set of SH2 domains binds BCR through a high-affinity phosphotyrosine-independent interaction.

Authors:  A J Muller; A M Pendergast; M H Havlik; L Puil; T Pawson; O N Witte
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

9.  Expression of epidermal growth factor receptors in human brain tumors.

Authors:  T A Libermann; N Razon; A D Bartal; Y Yarden; J Schlessinger; H Soreq
Journal:  Cancer Res       Date:  1984-02       Impact factor: 12.701

10.  Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth.

Authors:  F Bussolino; M F Di Renzo; M Ziche; E Bocchietto; M Olivero; L Naldini; G Gaudino; L Tamagnone; A Coffer; P M Comoglio
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

View more
  58 in total

1.  The molecular basis of phospholipase D2-induced chemotaxis: elucidation of differential pathways in macrophages and fibroblasts.

Authors:  Katie Knapek; Kathleen Frondorf; Jennalee Post; Stephen Short; Dianne Cox; Julian Gomez-Cambronero
Journal:  Mol Cell Biol       Date:  2010-07-20       Impact factor: 4.272

2.  Proliferation and motility responses of primary and recurrent gliomas related to changes in epidermal growth factor receptor expression.

Authors:  M E Berens; M D Rief; J R Shapiro; D Haskett; A Giese; A Joy; S W Coons
Journal:  J Neurooncol       Date:  1996-01       Impact factor: 4.130

3.  Directional migration and transcriptional analysis of oligodendrocyte precursors subjected to stimulation of electrical signal.

Authors:  Yongchao Li; Xinkun Wang; Li Yao
Journal:  Am J Physiol Cell Physiol       Date:  2015-08-12       Impact factor: 4.249

4.  Overactive Epidermal Growth Factor Receptor Signaling Leads to Increased Fibrosis after Severe Acute Respiratory Syndrome Coronavirus Infection.

Authors:  Thiagarajan Venkataraman; Christopher M Coleman; Matthew B Frieman
Journal:  J Virol       Date:  2017-05-26       Impact factor: 5.103

5.  Interferon-inducible protein 9 (CXCL11)-induced cell motility in keratinocytes requires calcium flux-dependent activation of mu-calpain.

Authors:  Latha Satish; Harry C Blair; Angela Glading; Alan Wells
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

6.  Mitogenic signaling from the egf receptor is attenuated by a phospholipase C-gamma/protein kinase C feedback mechanism.

Authors:  P Chen; H Xie; A Wells
Journal:  Mol Biol Cell       Date:  1996-06       Impact factor: 4.138

Review 7.  Growth factors in bladder cancer.

Authors:  M Liebert
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

8.  Small proline-rich proteins (SPRR) function as SH3 domain ligands, increase resistance to injury and are associated with epithelial-mesenchymal transition (EMT) in cholangiocytes.

Authors:  Anthony J Demetris; Susan Specht; Isao Nozaki; John G Lunz; Donna Beer Stolz; Noriko Murase; Tong Wu
Journal:  J Hepatol       Date:  2007-12-17       Impact factor: 25.083

9.  A G{alpha}i-GIV molecular complex binds epidermal growth factor receptor and determines whether cells migrate or proliferate.

Authors:  Pradipta Ghosh; Anthony O Beas; Scott J Bornheimer; Mikel Garcia-Marcos; Erin P Forry; Carola Johannson; Jason Ear; Barbara H Jung; Betty Cabrera; John M Carethers; Marilyn G Farquhar
Journal:  Mol Biol Cell       Date:  2010-05-12       Impact factor: 4.138

10.  Twist expression promotes migration and invasion in hepatocellular carcinoma.

Authors:  Noriyuki Matsuo; Hidenori Shiraha; Tatsuya Fujikawa; Nobuyuki Takaoka; Naoki Ueda; Shigetomi Tanaka; Shinichi Nishina; Yutaka Nakanishi; Masayuki Uemura; Akinobu Takaki; Shinichiro Nakamura; Yoshiyuki Kobayashi; Kazuhiro Nouso; Takahito Yagi; Kazuhide Yamamoto
Journal:  BMC Cancer       Date:  2009-07-18       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.